Nicola De Luca

Prof. Nicola De Luca

University Federico II, Naples, Campania, Italy
orcid

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
KPK.K. Poppe
K.K. Poppe
RDR.N. Doughty
R.N. Doughty
JGJ.M. Gardin
J.M. Gardin
FHF.D.R. Hobbs
F.D.R. Hobbs
JMJ.J.V. McMurray
J.J.V. McMurray
MSM. Salvetti
M. Salvetti

1 May 2013 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Open access
PMPaolo Melillo
Paolo Melillo
NLNicola De Luca
Nicola De Luca
MBMarcello Bracale
Marcello Bracale
LPLeandro Pecchia
Leandro Pecchia
This study aims to develop an automatic classifier for risk assessment in patients suffering from congestive heart failure (CHF). The proposed classifier separates lower risk patients from higher risk ones, using standard long-term heart rate variability (HRV) measures. Patients are labeled as lower or higher risk according to the New York Heart Association classification (NYHA). A retrospective analysis on two public Holter databases was performed, analyzing the data of 12 patients suffering from mild CHF (NYHA I and II), labeled as lower risk, and 32 suffering from severe CHF (NYHA III and IV), labeled as higher risk. Only patients with a fraction of total heartbeats intervals (RR) classified as normal-to-normal (NN) intervals (NN/RR) higher than 80% were selected as eligible in order to have a satisfactory signal quality. Classification and regression tree (CART) was employed to develop the classifiers. A total of 30 higher risk and 11 lower risk patients were included in the analysis. The proposed classification trees achieved a sensitivity and a specificity rate of 93.3% and 63.6%, respectively, in identifying higher risk patients. Finally, the rules obtained by CART are comprehensible and consistent with the consensus showed by previous studies that depressed HRV is a useful tool for risk assessment in patients suffering from CHF.

20 March 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PMPaolo Melillo
Paolo Melillo
RIRaffaele Izzo
Raffaele Izzo
AOAda Orrico
Ada Orrico
PSPaolo Scala
Paolo Scala
MAMarcella Attanasio
Marcella Attanasio
LPLeandro Pecchia
Leandro Pecchia
There is consensus that Heart Rate Variability is associated with the risk of vascular events. However, Heart Rate Variability predictive value for vascular events is not completely clear. The aim of this study is to develop novel predictive models based on data-mining algorithms to provide an automatic risk stratification tool for hypertensive patients. A database of 139 Holter recordings with clinical data of hypertensive patients followed up for at least 12 months were collected ad hoc. Subjects who experienced a vascular event (i.e., myocardial infarction, stroke, syncopal event) were considered as high-risk subjects. Several data-mining algorithms (such as support vector machine, tree-based classifier, artificial neural network) were used to develop automatic classifiers and their accuracy was tested by assessing the receiver-operator characteristics curve. Moreover, we tested the echographic parameters, which have been showed as powerful predictors of future vascular events. The best predictive model was based on random forest and enabled to identify high-risk hypertensive patients with sensitivity and specificity rates of 71.4% and 87.8%, respectively. The Heart Rate Variability based classifier showed higher predictive values than the conventional echographic parameters, which are considered as significant cardiovascular risk factors. Combination of Heart Rate Variability measures, analyzed with data-mining algorithm, could be a reliable tool for identifying hypertensive patients at high risk to develop future vascular events.

1 August 2004 in Journal Of Hypertension
Verified
Journal Article
Closed access
NLNicola De Luca
Nicola De Luca
RARoland G Asmar
Roland G Asmar
GLGérard M London
Gérard M London
MOMichael F O'ROurke
Michael F O'ROurke
MSMichel E Safar
Michel E Safar
In hypertension, blockade of the renin-angiotensin system reduces left ventricular mass (LVM) independently of brachial systolic (S), diastolic (D), and mean (M) blood pressure (BP). From central to peripheral arteries, MBP and DBP are practically unchanged, whereas SBP and pulse pressure (PP) increase significantly. The objective was to determine whether changes in LVM under drug treatment was preferentially associated with changes in central or brachial SBP and PP. A substudy of 146 subjects was selected from 469 hypertensive patients submitted to a double-blind randomized trial comparing the combination of perindopril (2 mg; Per) and indapamide (0.625 mg; Ind) with atenolol (50 mg, one tablet per day). Before and after 1 year of treatment: LVM (echocardiography) in 146 subjects and, in 52 of them, central (carotid) BP and timing of wave reflections (tonometry). LVM changes were significantly associated with antihypertensive treatment, with lower LVM with Per/Ind than with atenolol. Changes in SBP and PP, but not in MBP and DBP, were more significantly associated with Per/Ind than with atenolol, with more pronounced effects using central than brachial measurements, and a longer delay in central return of wave reflections under Per/Ind. In the sampling of 52 patients with tonometry, the change in LVM between the two drug regimens was significantly linked to central, but not brachial, PP change. This observational study shows a lower LVM under Per/Ind than under atenolol. The greater change in LVM on Per/Ind was linked to central and not brachial blood pressure.

1 June 1985 in American Heart Journal
Verified
Journal Article
Closed access
JBJ.D. Bouthier
J.D. Bouthier
NLNicola De Luca
Nicola De Luca
MSM.E. Safar
M.E. Safar
ASA.Ch. Simon
A.Ch. Simon

1 March 2001 in Stroke
Verified
Journal Article
Closed access
PDF file
GLGiuseppe Lembo
Giuseppe Lembo
NLNicola De Luca
Nicola De Luca
CBC. Battagli
C. Battagli
GIG. Iovino
G. Iovino
AAA. Aretini
A. Aretini
BTBruno Trimarco
Bruno Trimarco
Background and Purpose —Endothelium-derived NO is formed from l -arginine by endothelial NO synthase (eNOS) encoded by the NOS 3 gene on chromosome 7. Because several studies have indicated that NO plays a key role in the development of the atherosclerotic process, we investigated whether common variants in the eNOS gene are associated with an increased risk of plaque on carotid arteries. Methods —We studied 375 subjects attending the hypertension center of our institution to be screened for arterial hypertension. The examined subjects were classified according to the presence of carotid plaques (intima-media thickness ≥1.5 mm), and 2 intronic (CA and 27-bp repeats) polymorphisms and 1 exonic (Glu298Asp) polymorphism of the eNOS gene were explored. Results —Only the Glu298Asp polymorphism of eNOS was associated with the presence of carotid plaques ( P <0.05). In particular, there was an excess of homozygotes for the Asp298 variant among subjects with carotid plaques, whereas the number of subjects who had the Glu298 allele in exon 7 of the eNOS gene was equally distributed in both study groups. Interestingly, the risk of having carotid plaques was increased ≈3 times in subjects who were homozygotic for the Asp298 variant compared with subjects who were homozygotic for the Glu298 variant and was independent of the other common risk factors (age, blood pressure, and smoking). Conclusions —Homozygosity for Asp298, a common variant of the eNOS gene, is an independent risk factor for carotid atherosclerosis in this study population.